Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_assertion type Assertion NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_head.
- NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_assertion wasGeneratedBy ECO_0000203 NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_provenance.
- NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_assertion wasDerivedFrom befree-20140225 NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_provenance.
- NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_assertion SIO_000772 22236405 NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_provenance.
- NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_assertion evidence source_evidence_literature NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_provenance.
- NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_assertion description "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771066.RAGvAHCp3AUB2G3809rTDjDJcYRE5PzOUSFyX4Y8GwJAM130_provenance.